TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 779390

Group type: EXPERIMENTAL
Intervention: Atropine 0.01 mg/kg body weight given intramuscularly 1 hour before anaesthesia
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Atropine 0.01 mg/kg body weight given intravenously 5 minutes prior to induction
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Combination of intramuscular and intravenous atropine in the above-mentioned doses
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Atropine 0.015 mg/kg body weight intravenously 5 minutes prior to induction
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Large doses of atropine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Preoperative administration of atropine
Number of subjects: 68
Study: 31981777

Group type: EXPERIMENTAL
Intervention: 0.1% ginger extract
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 0.2% ginger extract (T3)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 0.4% ginger extract (T4)
Number of subjects: 360

Group type: COMPARATOR
Intervention: 0% ginger extract (Control)
Number of subjects: 360
Study: 30407077

Group type: EXPERIMENTAL
Intervention: Teacher-led Healthy Lifestyle Program (HEBAT module)
Number of subjects: 2635

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2635
Study: 26293616

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 1616
Study: 25039929

Group type: EXPERIMENTAL
Intervention: Horse simulator riding
Number of subjects: 47
Study: 22462516

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment, multifactorial interventions, and nurse-led care coordination
Number of subjects: 1281

Group type: COMPARATOR
Intervention: Care as usual by the general practitioner (GP)
Number of subjects: 1281
Study: 21374929

Group type: EXPERIMENTAL
Intervention: 35 microg ethinylestradiol (EE) with 2.0 mg cyproterone acetate/day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 30 microg ethinylestradiol (EE) with 2.0 mg dienogest/day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 30 microg ethinylestradiol (EE) with 3.0 mg drospirenone/day
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 90
Study: 18037776

Group type: EXPERIMENTAL
Intervention: losartan (50 mg/day)/HCTZ (12.5 mg/day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: candesartan (8 mg/day)/amlodipine (5 mg/day)
Number of subjects: 31
Study: 16116345

Group type: EXPERIMENTAL
Intervention: Fluvastatin or Simvastatin
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Ciprofibrate or Fenofibrate
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 12184480

Group type: EXPERIMENTAL
Intervention: Elated mood condition (induced by music and film)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sad mood condition (attempted induction through music and film)
Number of subjects: 0
Study: 10471591

Group type: EXPERIMENTAL
Intervention: 750 mg of levofloxacin once daily for 14 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1,000 mg of levofloxacin three times weekly for 14 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo once daily for 14 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo three times weekly for 14 days
Number of subjects: 30
Study: 8731513

Group type: EXPERIMENTAL
Intervention: Compression sclerotherapy using hypertonic saline
Number of subjects: 41

Group type: COMPARATOR
Intervention: High ligation of sapheno-femoral junction and local excision of varices (Control)
Number of subjects: 41
Study: 2116819

Group type: EXPERIMENTAL
Intervention: enprostil 35 micrograms bd
Number of subjects: 77

Group type: COMPARATOR
Intervention: pirenzepine 50 mg bd
Number of subjects: 77
Study: 7094195

Group type: EXPERIMENTAL
Intervention: Modified bicycle ergometer
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard bicycle ergometer
Number of subjects: 18
Study: 31910872

Group type: EXPERIMENTAL
Intervention: Pilates solo or belly dance classes three times per week for 16 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (receipt of a booklet on physical activity and maintenance of habitual physical activity routine)
Number of subjects: 0
Study: 30601291

Group type: EXPERIMENTAL
Intervention: EDOFL contact lens
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: EDOFH contact lens
Number of subjects: 16

Group type: COMPARATOR
Intervention: Single Vision (SV) contact lens
Number of subjects: 16
Study: 27765556

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 451

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 451
Study: 26773104

Group type: EXPERIMENTAL
Intervention: Swimming exercise training
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cycling exercise training
Number of subjects: 48
Study: 25061219

Group type: EXPERIMENTAL
Intervention: EVLR
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 24187901

Group type: EXPERIMENTAL
Intervention: Calcium supplement plus low-dose aspirin (500 mg carbonate calcium plus 80 mg aspirin)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 19815692

Group type: EXPERIMENTAL
Intervention: HIV vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cancer treatment
Number of subjects: 0
Study: 17934663

Group type: EXPERIMENTAL
Intervention: HBP+DM2 group
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Hypertensive patients with DM2
Number of subjects: 89

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 89
Study: 16326339

Group type: EXPERIMENTAL
Intervention: 0.1% levobupivacaine infusion
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 12191747

Group type: EXPERIMENTAL
Intervention: Lisinopril 5 mg o.d.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lisinopril 20 mg o.d.
Number of subjects: 12
Study: 9790371

Group type: EXPERIMENTAL
Intervention: Methylprednisolone, 16 mg 3 times daily, tapered over 2 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Promethazine, 25 mg 3 times daily, continued for 2 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Promethazine
Number of subjects: 40
Study: 7608705

Group type: EXPERIMENTAL
Intervention: Ictal SPECT
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Postictal SPECT
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Interictal SPECT
Number of subjects: 177
Study: 1978477

Group type: EXPERIMENTAL
Intervention: Remoxipride (90-600 mg daily)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Haloperidol (5-45 mg daily)
Number of subjects: 145
Study: 6768492

Group type: EXPERIMENTAL
Intervention: 10 microgram HOE 766 i.m.
Number of subjects: 5
Study: 31817245

Group type: EXPERIMENTAL
Intervention: CuOx/CNF (copper oxide microelectrode arrays dispersed within carbon nanofiber paste)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CuOx/CNF
Number of subjects: 0
Study: 26658434

Group type: EXPERIMENTAL
Intervention: Uphill sprint training (UST) - 10 x 10 sec sprints with 60s recovery on a 7% gradient for six weeks, twice weekly
Number of subjects: 14

Group type: COMPARATOR
Intervention: Normal activity (Control)
Number of subjects: 14
Study: 25862743

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 3501
Study: 23665733

Group type: EXPERIMENTAL
Intervention: Negatively-charged polystyrene microspheres (NCM)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (saline soaks)
Number of subjects: 58
Study: 22929843

Group type: EXPERIMENTAL
Intervention: Ultrasound with nerve stimulation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nerve stimulation
Number of subjects: 70
Study: 19638366

Group type: EXPERIMENTAL
Intervention: Aggressive blood pressure lowering targeting SBP <130 mmHg using a combination of amlodipine/valsartan and additional antihypertensive medications as needed.
Number of subjects: 228

Group type: COMPARATOR
Intervention: Standard blood pressure lowering targeting SBP <140 mmHg using a combination of amlodipine/valsartan and additional antihypertensive medications as needed.
Number of subjects: 228
Study: 19352059

Group type: EXPERIMENTAL
Intervention: 1.5 mg/d MK-4 for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 40
Study: 16389774

Group type: COMPARATOR
Intervention: Whitening strips (10% hydrogen peroxide)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Pre-brushing mouthrinse (2% hydrogen peroxide)
Number of subjects: 28
Study: 12469001

Group type: EXPERIMENTAL
Intervention: Tetrabenazine (TBZ) at a final mean dose of 62.5 ± 37.4 mg/day (range 25‐150)
Number of subjects: 19
Study: 9469353

Group type: EXPERIMENTAL
Intervention: Intensified chemotherapy (V-ICE every 3 weeks)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard chemotherapy (V-ICE every 4 weeks)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF) 250 microg/m2/d for 14 days between chemotherapy cycles
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 7879258

Group type: EXPERIMENTAL
Intervention: Donor-specific transfusions (DST) with continuous Aza immunosuppression
Number of subjects: 163
Study: 2229451

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (750 mg every 12 hours for 5 days before and 24 hours after quinidine administration)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Quinidine sulfate (400 mg administered alone)
Number of subjects: 7
Study: 361794

Group type: EXPERIMENTAL
Intervention: Prednisone 30 mg daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 24
Study: 12577250

Group type: EXPERIMENTAL
Intervention: Subcutaneous amifostine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intravenous amifostine
Number of subjects: 54

Group type: COMPARATOR
Intervention: No amifostine
Number of subjects: 54
Study: 31819309

Group type: EXPERIMENTAL
Intervention: Protein supplementation and fortification of breast milk (FMS-Aptamil-DANON) during NICU hospitalization, with protein added when milk reached 100 cc/kg/day, increased by 20 cc/kg/day until 150-180 cc/kg/day, stopped when weight reached 1500 grams.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Protein supplementation and fortification of breast milk (FMS-Aptamil-DANON) during NICU hospitalization.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group fed similar to intervention group without protein supplementation.
Number of subjects: 36
Study: 29408510

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (before manufacturing change)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (after manufacturing change)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonclinical assessments
Number of subjects: 0
Study: 26553744

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 24691852

Group type: EXPERIMENTAL
Intervention: Topical 0.5 % bupivacaine hydrochloride
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical 0.9 % NaCl (saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine hydrochloride infiltration
Number of subjects: 60
Study: 23214214

Group type: EXPERIMENTAL
Intervention: Increasing PEEP trial
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Decreasing PEEP trial
Number of subjects: 60

Group type: COMPARATOR
Intervention: PEEP/FiO2 tables
Number of subjects: 60
Study: 20870099

Group type: EXPERIMENTAL
Intervention: Immediate carotid endarterectomy (CEA)
Number of subjects: 3120

Group type: COMPARATOR
Intervention: Deferred carotid procedure
Number of subjects: 3120
Study: 17566091

Group type: EXPERIMENTAL
Intervention: 0.3 mg rhTSH
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study: 15607836

Group type: EXPERIMENTAL
Intervention: High level of cocaine use during the 2-week lead-in period
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Smoking as the primary route of cocaine use
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low level of cocaine use during the 2-week lead-in period
Number of subjects: 50
Study: 12383289

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Piroxicam
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Combination of piroxicam and dexamethasone
Number of subjects: 200
Study: 10024065

Group type: EXPERIMENTAL
Intervention: BDI scores > or =10 (depressed women)
Number of subjects: 896

Group type: COMPARATOR
Intervention: BDI scores <10 (nondepressed women)
Number of subjects: 896

Group type: EXPERIMENTAL
Intervention: BDI scores > or =10 (depressed men)
Number of subjects: 896

Group type: COMPARATOR
Intervention: BDI scores <10 (nondepressed men)
Number of subjects: 896

Group type: EXPERIMENTAL
Intervention: Increased BDI scores (both genders)
Number of subjects: 896
Study: 7790649

Group type: EXPERIMENTAL
Intervention: Pulsed single-tone suppressors
Number of subjects: 6
Study: 2349410

Group type: EXPERIMENTAL
Intervention: Magnesium (3 X 5 mmol granulate orally on the day preceding menstruation and on the first and second day of the cycle)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Magnesium
Number of subjects: 32
Study: 208825

Group type: EXPERIMENTAL
Intervention: pivmecillinam
Number of subjects: 0

Group type: COMPARATOR
Intervention: amoxycillin
Number of subjects: 0
Study: 30701349

Group type: EXPERIMENTAL
Intervention: Psychosexual counseling (6 weekly sessions, 90 to 120 min each)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 118
Study: 29979423

Group type: EXPERIMENTAL
Intervention: AHE with real-time ultrasound imaging feedback (group B)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional feedback (group A)
Number of subjects: 20
Study: 27149770

Group type: EXPERIMENTAL
Intervention: Confidential feedback of data and tailor-made problem-solving workshops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 24568229

Group type: EXPERIMENTAL
Intervention: Jump-landing task and knee-laxity assessment 3 to 5 days after the onset of menses
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Jump-landing task and knee-laxity assessment within 3 days of a positive ovulation test
Number of subjects: 20
Study: 21667354

Group type: EXPERIMENTAL
Intervention: Radiotherapy quality assurance (QA) for JCOG 0303
Number of subjects: 106

Group type: COMPARATOR
Intervention: Institutions enrolling <7 patients
Number of subjects: 106
Study: 20568090

Group type: EXPERIMENTAL
Intervention: Motor task (reaction time) in patients with PD
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Visual learning task in patients with PD
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Reaction times in patients with PD
Number of subjects: 23

Group type: COMPARATOR
Intervention: Motor task (reaction time) in healthy controls
Number of subjects: 23

Group type: COMPARATOR
Intervention: Visual learning task in healthy controls
Number of subjects: 23
Study: 17320962

Group type: EXPERIMENTAL
Intervention: Vitamin therapy (antioxidants plus zinc)
Number of subjects: 20000000

Group type: COMPARATOR
Intervention: No vitamin therapy
Number of subjects: 20000000
Study: 15667826

Group type: EXPERIMENTAL
Intervention: Speed limit increased from 50 to 70 km/h
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Speed limit increased from 70 to 80 km/h
Number of subjects: 19
Study: 11179081

Group type: EXPERIMENTAL
Intervention: Oral methionine loading
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9735650

Group type: EXPERIMENTAL
Intervention: Surgical treatment without drainage
Number of subjects: 59

Group type: COMPARATOR
Intervention: Surgical treatment with tube drainage
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study: 8138773

Group type: EXPERIMENTAL
Intervention: Interview or postal questionnaire before invitation for breast screening
Number of subjects: 3291

Group type: COMPARATOR
Intervention: Control group (no interview)
Number of subjects: 3291

Group type: EXPERIMENTAL
Intervention: Health behaviours and attitudes
Number of subjects: 3291

Group type: EXPERIMENTAL
Intervention: Attitudes, beliefs, and intentions
Number of subjects: 3291
Study: 3395914

Group type: EXPERIMENTAL
Intervention: Diltiazem 2.0 mg given every 6 h
Number of subjects: 1

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 1

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 1

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 1
Study: 31131103

Group type: EXPERIMENTAL
Intervention: Education package delivered to mothers (nutrition, stimulation, hygiene education)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Routine health care (control group)
Number of subjects: 155
Study: 28634703

Group type: EXPERIMENTAL
Intervention: Isoperistaltic side-to-side anastomosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antiperistaltic side-to-side anastomosis
Number of subjects: 0
Study: 26085538

Group type: EXPERIMENTAL
Intervention: Video review with an orthopaedic traumatologist (intervention group, n=8)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No video review (control group, n=7)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 15
Study: 23443254

Group type: EXPERIMENTAL
Intervention: Anastrozole treatment in compliant patients
Number of subjects: 63

Group type: COMPARATOR
Intervention: Anastrozole treatment in non-compliant patients
Number of subjects: 63
Study: 20731735

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 739

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 739
Study: 19951540

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT) with interrupted suction under a pressure of -16.63 kPa for 24 hours or continuous suction under a pressure of -10.64 kPa for 24 hours.
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional treatment (CT) with petrolatum gauze overlaid with isotonic saline gauze and dry gauze.
Number of subjects: 67
Study: 17029523

Group type: EXPERIMENTAL
Intervention: Transbond Plus Self‐Etching adhesive
Number of subjects: 30

Group type: COMPARATOR
Intervention: Transbond XT conventional adhesive
Number of subjects: 30
Study: 12523456

Group type: EXPERIMENTAL
Intervention: Erythromycin 3.0 mg/kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11142415

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (vitamins C and E and beta-carotene)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 9109903

Group type: EXPERIMENTAL
Intervention: Clozapine (39 mg/day)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Benztropine (3.0 mg/day)
Number of subjects: 22
Study: 7942174

Group type: EXPERIMENTAL
Intervention: Opening of the lamina terminalis and Lilliequist's membrane
Number of subjects: 197
Study: 3281872

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth (120 mg administered through an intraoesophageal tube four times a day) + Cimetidine (800 mg at night)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cimetidine alone (800 mg at night)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth + Cimetidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cimetidine alone
Number of subjects: 20
Study: 31314661

Group type: EXPERIMENTAL
Intervention: Web-Based Multimedia Intervention (WBMI)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Educational Pamphlet
Number of subjects: 160
Study: 29973170

Group type: EXPERIMENTAL
Intervention: Locally produced maternal food-based supplementation
Number of subjects: 87
Study: 27998216

Group type: EXPERIMENTAL
Intervention: Statin use in SELECT
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Statin use in PCPT
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Black ethnicity in SELECT
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Black ethnicity in PCPT
Number of subjects: 2
Study: 25915944

Group type: EXPERIMENTAL
Intervention: PET/CT-guided dose escalation chemoradiotherapy (group C)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: CT-guided dose escalation chemoradiotherapy (group B)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional chemoradiotherapy (group A)
Number of subjects: 67
Study: 23422371

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 202
Study: 19785620

Group type: COMPARATOR
Intervention: Placebo-controlled studies
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Median study duration
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Psoriasis Area and Severity Index score
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Quality of life measure
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Pharmaceutical company sponsorship
Number of subjects: 140
Study: 18382182

Group type: EXPERIMENTAL
Intervention: Topiramate (400 mg/d or maximum tolerated dose)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 16362532

Group type: EXPERIMENTAL
Intervention: 20 mg methylprednisolone injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 60 mg methylprednisolone injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One or two injections of methylprednisolone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups (20 mg, 40 mg, 60 mg)
Number of subjects: 0
Study: 11914933

Group type: EXPERIMENTAL
Intervention: UFT (uracil and tegafur) administered at 400 mg/day for 2 years
Number of subjects: 289

Group type: COMPARATOR
Intervention: Control group (surgery alone)
Number of subjects: 289